Cargando…

Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation Carriers

The purpose of this study was to investigate whether differential phosphorylation states of blood markers can identify patients with LRRK2 Parkinson's disease (PD). We assessed phospho(P)‐Ser‐935‐LRRK2 and P‐Ser‐473‐AKT levels in peripheral blood cells from patients with G2019S LRRK2‐associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garrido, Alicia, Pérez‐Sisqués, Leticia, Simonet, Cristina, Campoy‐Campos, Genís, Solana‐Balaguer, Júlia, Martín‐Flores, Núria, Fernández, Manel, Soto, Marta, Obiang, Donina, Cámara, Ana, Valldeoriola, Francesc, Muñoz, Esteban, Compta, Yaroslau, Pérez‐Navarro, Esther, Alberch, Jordi, Tolosa, Eduardo, Martí, María‐José, Ezquerra, Mario, Malagelada, Cristina, Fernández‐Santiago, Rubén
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827833/ https://www.ncbi.nlm.nih.gov/pubmed/35929078 http://dx.doi.org/10.1002/ana.26469

Ejemplares similares

Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease
por: Garrido, Alicia, et al.
Publicado: (2022)

Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Fernández-Santiago, Rubén, et al.
Publicado: (2021)

RTP801 mediates transneuronal toxicity in culture via extracellular vesicles
por: Solana‐Balaguer, Júlia, et al.
Publicado: (2023)

Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers
por: Pont-Sunyer, Claustre, et al.
Publicado: (2015)

RTP801/REDD1 Is Involved in Neuroinflammation and Modulates Cognitive Dysfunction in Huntington’s Disease
por: Pérez-Sisqués, Leticia, et al.
Publicado: (2021)

RTP801/REDD1 contributes to neuroinflammation severity and memory impairments in Alzheimer’s disease
por: Pérez-Sisqués, Leticia, et al.
Publicado: (2021)

Neuron‐derived extracellular vesicles contain synaptic proteins, promote spine formation, activate TrkB‐mediated signalling and preserve neuronal complexity
por: Solana‐Balaguer, Julia, et al.
Publicado: (2023)

Emergencies and critical issues in Parkinson’s disease
por: Simonet, Cristina, et al.
Publicado: (2020)

Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report
por: Torres, Viviana, et al.
Publicado: (2022)

l‐Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior
por: Valldeoriola, Francesc, et al.
Publicado: (2017)

Synaptic RTP801 contributes to motor-learning dysfunction in Huntington’s disease
por: Martín-Flores, Núria, et al.
Publicado: (2020)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

(123)I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations
por: Valldeoriola, Francesc, et al.
Publicado: (2011)

R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
por: Fan, Ying, et al.
Publicado: (2021)

Identifying the genetic components underlying the pathophysiology of movement disorders
por: Ezquerra, Mario, et al.
Publicado: (2011)

Loss of NEDD4 contributes to RTP801 elevation and neuron toxicity: implications for Parkinson's disease
por: Canal, Mercè, et al.
Publicado: (2016)

Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's disease
por: Podlesniy, Petar, et al.
Publicado: (2019)

Transcriptomic differences in MSA clinical variants
por: Pérez-Soriano, Alexandra, et al.
Publicado: (2020)

Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer
por: Barrantes, Sergi, et al.
Publicado: (2017)

Cognitive Behavioral Therapy Plus a Serious Game as a Complementary Tool for a Patient With Parkinson Disease and Impulse Control Disorder: Case Report
por: Mena-Moreno, Teresa, et al.
Publicado: (2022)

Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy
por: Abos, Alexandra, et al.
Publicado: (2019)

Patterns of cortical thinning in nondemented Parkinson's disease patients
por: Uribe, Carme, et al.
Publicado: (2016)

Discriminating cognitive status in Parkinson’s disease through functional connectomics and machine learning
por: Abós, Alexandra, et al.
Publicado: (2017)

Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
por: Soto, Marta, et al.
Publicado: (2023)

Disrupted functional connectivity in PD with probable RBD and its cognitive correlates
por: Oltra, Javier, et al.
Publicado: (2021)

Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease
por: Romaní-Aumedes, J, et al.
Publicado: (2014)

Effects of COVID -19 pandemic and lockdown on people with multiple system atrophy participating in a therapeutic education program
por: Cámara, Ana, et al.
Publicado: (2021)

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2(G2019S)-Parkinson’s disease
por: Juárez-Flores, Diana Luz, et al.
Publicado: (2018)

Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus
por: Juárez-Flores, Diana Luz, et al.
Publicado: (2020)

Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease
por: Gomes, Sara, et al.
Publicado: (2023)

Statistical inference in brain graphs using threshold‐free network‐based statistics
por: Baggio, Hugo C., et al.
Publicado: (2018)

Sex Differences in Brain and Cognition in de novo Parkinson's Disease
por: Oltra, Javier, et al.
Publicado: (2022)

Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction
por: Compta, Yaroslau, et al.
Publicado: (2021)

Altered expression of the immunoregulatory ligand-receptor pair CD200-CD200R1 in the brain of Parkinson’s disease patients
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2022)

Gray/White Matter Contrast in Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson’s Disease
por: Garcia-Diaz, Anna Isabel, et al.
Publicado: (2017)

Sex differences in brain atrophy and cognitive impairment in Parkinson’s disease patients with and without probable rapid eye movement sleep behavior disorder
por: Oltra, Javier, et al.
Publicado: (2021)

Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairment
por: Oltra, Javier, et al.
Publicado: (2022)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0np8kmti7v2bheb6517lrdntik